Cargando…

COVID-19 natural herd immunity and risk of neuropsychiatric disorders

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Losilla-Rodríguez, Beatriz, Maldonado, Natalia, Moreno-Mellado, Elisa, López-Díaz, Álvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SEP y SEPB. Published by Elsevier España, S.L.U. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444933/ http://dx.doi.org/10.1016/j.rpsm.2020.07.002

Ejemplares similares

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

Herd immunity: Deadly or defensive
por: Khan, Sameena, et al.
Publicado: (2021)

COVID-19, Herd Immunity and Vaccine
por: Tin, Sim Sai, et al.
Publicado: (2023)

Neurological and neuropsychiatric disorders associated with COVID-19. Part II: neuropsychiatric disorders and final consideration
por: Giacalone, Martina, et al.
Publicado: (2021)

Risk of neuropsychiatric disorders in offspring of COVID-19-infected pregnant women and nutritional intervention
por: Hashimoto, Kenji
Publicado: (2020)

Can India develop herd immunity against COVID-19?
por: Gowrisankar, A., et al.
Publicado: (2020)

Neuropsychiatric manifestations in patients with long COVID in Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Perspectives on the Zika outbreak: herd immunity, antibody-dependent enhancement and vaccine
por: Silva, José Valter Joaquim, et al.
Publicado: (2017)

Timeliness and obsolescence of herd immunity threshold estimates in the COVID-19 pandemic
por: Gomes, M.G.M.
Publicado: (2022)

Response to “Moghnieh et al. COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be Prepared”
por: Khalid, Dua, et al.
Publicado: (2020)

Bipolar affective disorder in Huntington's disease: A neuropsychiatric perspective
por: Raj, Rajnish, et al.
Publicado: (2015)

Neurological and neuropsychiatric disorders associated with COVID-19. Part I: overview and neurological disorders
por: Giacalone, Martina, et al.
Publicado: (2021)

Herd immunity against COVID-19: is it enough to stop a second wave?
por: AbdAllah, M., et al.
Publicado: (2020)

Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
por: KWOK, Kin On, et al.
Publicado: (2021)

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

Neuropsychiatric Consequences of Deep Brain Stimulation in Patients with Chronic Movement Disorders
por: Malakouti, Seyed Kazem, et al.
Publicado: (2016)

Hypotheses on the neuroimmune cross-talk between COVID-19 and neuropsychiatric disorders
por: Senra, Hugo
Publicado: (2021)

An incentive-based approach may be the only approach to achieve COVID-19 herd immunity
por: Fradkin, C.
Publicado: (2021)

Neuropsychiatric Lupus: The Devil is in the Detail
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2019)

Challenges with neuropsychiatric Wilson's disease
por: Åberg, Fredrik, et al.
Publicado: (2023)

Helicobacter Pylori-Related Vitamin B12 Deficiency: A Potential Contributor in Neuropsychiatric Disorders
por: Kountouras, Jannis, et al.
Publicado: (2015)

Wilson′s disease Presenting with Neuropsychiatric Manifestations.
por: Jacob, Rajesh, et al.
Publicado: (2004)

COVID-19 vaccination and herd immunity In Africa: An incentive-based approach could be the game-changer to vaccine hesitancy
por: Onigbinde, Oluwanisola Akanji, et al.
Publicado: (2022)

Spread of Vaccinia Virus to Cattle Herds, Argentina, 2011
por: Franco-Luiz, Ana Paula Moreira, et al.
Publicado: (2014)

Influenza D Virus Infection in Herd of Cattle, Japan
por: Murakami, Shin, et al.
Publicado: (2016)

Omicron and other variants of SARS-CoV-2 roles of vaccines and herd immunity in protecting from the emerging strains
por: Pustake, Manas, et al.
Publicado: (2022)

How Long that a SARS-CoV-2 Variant Delay Impacts Required Period to Achieve Herd Immunity?
por: Joob, Beuy, et al.
Publicado: (2023)

Neuropsychiatric manifestations in a child with moyamoya disease
por: Mohapatra, Satyakam, et al.
Publicado: (2016)

COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
por: Yasri, Sora, et al.
Publicado: (2022)

Biallelic ZBTB11 variants associated with complex neuropsychiatric phenotype featuring Tourette syndrome
por: Scala, Marcello, et al.
Publicado: (2022)

Neuropsychiatric complications of SLE: Raising some issues of concern
por: Pattanayak, Raman Deep, et al.
Publicado: (2011)

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Raina, Sunil Kumar
Publicado: (2015)

Neuropsychiatric manifestations in a child with agenesis of the corpus callosum
por: Mohapatra, Satyakam, et al.
Publicado: (2015)

Neuropsychiatric Symptoms as Early Manifestation of Progressive Supranuclear Palsy
por: Suthar, Navratan, et al.
Publicado: (2018)

Covid-19 treatment-induced neuropsychiatric adverse effects
por: García, C.A. Carrajo, et al.
Publicado: (2020)

A case of neurocysticercosis: Neuropsychiatric manifestations, course, and treatment
por: Gournellis, Rossetos, et al.
Publicado: (2019)

Pediatric Acute-Onset Neuropsychiatric Syndrome with Capgras Syndrome
por: Sharawat, Indar Kumar, et al.
Publicado: (2021)

Neuropsychiatric outcome in attempted hanging: A case report
por: Aziz, Sadaf, et al.
Publicado: (2021)

Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Neuropsychiatric symptoms in community‐dwelling older Brazilians with mild cognitive impairment and dementia
por: Suemoto, Claudia Kimie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r5u4uvbo36drs2lf02fn5cl2cm